Emergent BioSolutions Aktie
WKN DE: A0LC2W / ISIN: US29089Q1058
30.04.2021 23:54:00
|
Emergent BioSolutions Inc. -- Moody's affirms Emergent's Ba2 CFR; revises outlook to negative
Rating Action: Moody's affirms Emergent's Ba2 CFR; revises outlook to negativeVollständigen Artikel bei Moodys lesen